The Ratio of Messenger RNA Levels of Receptor Activator of Nuclear Factor κB Ligand to Osteoprotegerin Correlates with Bone Remodeling Indices in Normal Human Cancellous Bone but Not in Osteoarthritis

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483 · see citing works

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290 · see citing works

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · see citing works

RANK is essential for osteoclast and lymph node development.

Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478 · see citing works

The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,167 · see citing works

TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells

Wong, B. R., Rho, J., Arron, J. R., Robinson, E. A., Orlinick, J. R., Chao, M. V., Kalachikov, S. M., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042 · see citing works

Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone

Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001 · see citing works

Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1

Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-602

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650 · see citing works

ROLE OF MECHANICAL FACTORS IN PATHOGENESIS OF PRIMARY OSTEOARTHRITIS

Radin, E., Paul, I., & Rose, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90179-1 · Cited by 595 · see citing works

Composition and Mechanical Properties of Cancellous Bone from the Femoral Head of Patients with Osteoporosis or Osteoarthritis

Li, B., & Aspden, R. M. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.641 · Cited by 461 · see citing works

Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells

Horwood, N. J., Elliott, J., Martin, T. J., & Gillespie, M. T. (1998) · Endocrinology · doi:10.1210/endo.139.11.6433 · Cited by 456 · see citing works

Radiographic osteoarthritis of the hip and bone mineral density

Nevitt, M. C., Lane, N. E., Scott, J. C., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380706 · Cited by 364 · see citing works

Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues

Kartsogiannis, V., Zhou, H., Horwood, N. J., Thomas, R. J., Hards, D. K., Quinn, J. M. W., Niforas, P., Ng, K. W., Martin, T. J., & Gillespie, M. T. (1999) · Bone · doi:10.1016/s8756-3282(99)00214-8 · Cited by 324 · see citing works

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299 · see citing works

The Pathology of Articular and Spinal Diseases.

&NA; (1950) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195022040-00015 · Cited by 216 · see citing works

Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors

Atkins, G. J., Haynes, D. R., Graves, S. E., Evdokiou, A., Hay, S. J., Bouralexis, S., & Findlay, D. M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.640 · Cited by 197 · see citing works

Generalized osteoarthritis associated with increased insulin‐like growth factor types i and ii and transforming growth factor β in cortical bone from the iliac crest. possible mechanism of increased bone density and protection against osteoporosis

Dequeker, J., Mohan, S., Finkelman, R. D., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361209 · Cited by 191 · see citing works

Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity

Martin, T. J., & Ng, K. W. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560312 · Cited by 173 · see citing works

Osteoarthritis: A review of the cell biology involved and evidence for reversibility. Management rationally related to known genesis and pathophysiology

Bland, J. H., & Cooper, S. M. (1984) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(84)90002-7 · Cited by 114 · see citing works

Interleukins in the Control of Osteoclast Differentiation

Martin, T. J., Romas, E., & Gillespie, M. T. (1998) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v8.i2.10 · Cited by 111 · see citing works

INVERSE RELATIONSHIP OSTEOARTHRITIS—OSTEOPOROSIS: WHAT IS THE EVIDENCE? WHAT ARE THE CONSEQUENCES?

Dequeker, J., Boonen, S., Aerssens, J., & Westhovens, R. (1996) · Lara D. Veeken · doi:10.1093/rheumatology/35.9.813 · Cited by 111 · see citing works

The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling site

Boyce, R. W., Paddock, C. L., Gleason, J. R., Sletsema, W. K., & Eriksen, E. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100207 · Cited by 99 · see citing works

Femoral Trabecular Bone of Osteoarthritic and Normal Subjects in an Age and Sex Matched Group

Fazzalari, N. L., & Parkinson, I. H. (1998) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0141 · Cited by 80 · see citing works

Enhanced Expression of Osteocalcin mRNA in Human Osteoarthritic Trabecular Bone of the Proximal Femur Is Associated with Decreased Expression of Interleukin-6 and Interleukin-11 mRNA

Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.332 · Cited by 50 · see citing works

Histomorphometric changes in the trabecular structure of a selected stress region in the femur in patients with osteoarthritis and fracture of the femoral neck

Fazzalari, N. L., Darracott, J., & Vernon-Roberts, B. (1985) · Bone · doi:10.1016/8756-3282(85)90044-4 · Cited by 50 · see citing works

Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation

Schett, G. A., Steiner, G. E., & Smolen, J. S. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8 · Cited by 44 · see citing works

Age-Related Changes in Femoral Trabecular Bone in Arthrosis

Crane, G. J., Fazzalari, N. L., Parkinson, I. H., et al. (1990) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679008993554 · Cited by 35 · see citing works

Remodelling of subchondral bone in osteoarthritis: a histomorphometric study.

Amir, G., Pirie, C. J., Rashad, S., et al. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.11.990 · Cited by 32 · see citing works

Comparative study of iliac crest and subchondral femoral bone in osteoarthritic patients

Fazzalari, N. L., Moore, R. J., Manthey, B. A., et al. (1992) · Bone · doi:10.1016/8756-3282(92)90079-c · Cited by 31 · see citing works

Untitled work

(1998) · doi:10.1002/1529-0131(199806)41:6

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824 · see citing works

Osteoporosis, inflammation and ageing

Ginaldi, L., Di Benedetto, M. C., & De Martinis, M. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-14 · Cited by 412 · see citing works

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

KOSTENUIK, P. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.06.005 · Cited by 281 · see citing works

RANKL Expression Is Related to the Differentiation State of Human Osteoblasts

Atkins, G. J., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., Harrison, K., Findlay, D. M., & Zannettino, A. C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1088 · Cited by 245 · see citing works

Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.

Cao, J., Venton, L., Sakata, T., & Halloran, B. P. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.270 · Cited by 173 · see citing works

Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.

Indridason, O. S., Franzson, L., & Sigurdsson, G. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1699-x · Cited by 107 · see citing works

Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.

Tsangari, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., & Fazzalari, N. L. (2004) · Bone · doi:10.1016/j.bone.2004.02.006 · Cited by 69 · see citing works

Serum osteoprotegerin and its ligand in Paget’s disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.

Alvarez, L., Peris, P., Guañabens, N., Vidal, S., Ros, I., Pons, F., Filella, X., Monegal, A., Muñoz‐Gomez, J., & Ballesta, A. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10834 · Cited by 66 · see citing works

Increased RANKL/OPG mRNA Ratio in Iliac Bone Biopsies From Women with Hip Fractures

Abdallah, B. M., Stilgren, L. S., Nissen, N., Kassem, M., Jørgensen, H. R. I., & Abrahamsen, B. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0074-4 · Cited by 60 · see citing works

Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis

Samara, S., Dailiana, Z. H., Chassanidis, C., Koromila, T., Papatheodorou, L. K., Malizos, Κ. Ν., & Κollia, P. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.10.014 · Cited by 37 · see citing works

Rank/Rankl/opg: literature review.

(2011) · PubMed · Cited by 170 · see citing works

Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head.

Xiong, M., Liu, L.-Q., Liu, S.-Q., Liu, Z., & Gao, H. (2016) · Europe PMC (PubMed Central) · Cited by 11 · see citing works

Expression Profiles of Receptor Activator of Nuclear Factor κB Ligand, Receptor Activator of Nuclear Factor κB, and Osteoprotegerin Messenger RNA in Aged and Ovariectomized Rat Bones

Ikeda, T., Utsuyama, M., & Hirokawa, K. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1416 · Cited by 107 · see citing works

Osteoclastogenesis regulatory factors (RANK, RANKL and OPG) in osteolytic jaw lesions

de Moraes, M., de Matos, F. R., & Costa, A. D. L. L. (2013) · Revista Odonto Ciência